Emerging pathogens in nosocomial pneumonia

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
S L Berk, A Verghese

Abstract

The organisms responsible for nosocomial pneumonia are continuously evolving. Gram-negative bacilli have become the most common etiologic agents over the past 20 years, and with this evolution has come a better understanding of the pathogenesis of gram-negative bacillary pneumonia. Some gram-positive cocci, such as enterococci, group B beta hemolytic streptococci and methicillin-resistant Staphylococcus aureus, haven taken on new significance in nosocomial respiratory infections. Streptococcus pneumoniae, nontypeable Haemophilus influenzae and Branhamella catarrhalis are increasingly reported in hospitalized patients with chronic lung disease. Etiologic agents will change as new antibiotics are introduced. A better understanding of etiologic agents and their pathogens may be the best tool toward preventing hospital-acquired pneumonia.

References

May 1, 1977·Medicine·M ValdiviesoG P Bodey
May 1, 1988·The Journal of Infectious Diseases·T F PattersonM J Zervos
Jan 1, 1988·Journal of Gerontology·S AlvarezJ K Smith
Nov 1, 1987·Reviews of Infectious Diseases·H HagerS L Berk
Feb 1, 1988·The American Journal of the Medical Sciences·O EkennaS L Berk
Aug 1, 1986·Archives of Internal Medicine·S AlvarezS L Berk
Feb 1, 1985·Southern Medical Journal·S L BerkJ K Smith
Jul 15, 1985·The American Journal of Medicine·A KarnadS L Berk
Apr 1, 1984·Infection and Immunity·R RamphalJ D Silipigni
Sep 1, 1983·Medicine·A Verghese, S L Berk
Jan 1, 1983·The American Journal of Medicine·R B Fick, H Y Reynolds
Nov 1, 1983·Archives of Internal Medicine·J P PhairE Metzger
May 1, 1984·The American Review of Respiratory Disease·C S Bryan, K L Reynolds
Jun 1, 1980·Archives of Pathology & Laboratory Medicine·A M Dvorak
Mar 1, 1980·The American Journal of Medicine·B E KregerW R McCabe
Sep 1, 1982·Archives of Internal Medicine·A VergheseJ K Smith
Feb 1, 1980·The American Journal of Medicine·P A GrossN Aswapokee
Feb 1, 1981·Southern Medical Journal·S L BerkJ K Smith
Mar 1, 1938·American Journal of Public Health and the Nation's Health·W G SmillieH J White

❮ Previous
Next ❯

Citations

Jan 1, 1992·Intensive Care Medicine·K E UnertlK Peter
Nov 1, 1993·International Journal of Antimicrobial Agents·H Giamarellou
Jun 23, 1998·Journal of Clinical Epidemiology·G KampfF Daschner
Jul 1, 1992·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·G Gibson, E Barrett
Dec 1, 1995·Antimicrobial Agents and Chemotherapy·M J BontenE E Stobberingh
Jan 10, 2002·Clinical Microbiology Reviews·Cees M VerduinAlex van Belkum
Apr 2, 2005·Clinics in Chest Medicine·Jordi RelloAlejandro Rodríguez
Apr 9, 1990·The American Journal of Medicine·J Modai
Nov 4, 2005·Journal of the Chinese Medical Association : JCMA·Ying-Ying Yang, Han-Chieh Lin
Feb 1, 1997·Current Problems in Surgery·H C PolkW G Cheadle

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.